Bone regeneration

Stem cell therapies and clinical studies in orthopaedics and traumatology

Enrique Gómez-Barrena, Philippe Rosset, Ingo Müller, Rosaria Giordano, Carmen Bunu, Pierre Layrolle, Yrjö T. Konttinen, Frank P. Luyten

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

• Introduction • Characterization of cells for bone regeneration in human beings • State of the art in bone tissue engineering - Biomaterials for scaffolding mesenchymal stem cells - Future trends in bone tissue engineering • Clinical targets for cell therapy in orthopaedics - Current clinical problems and therapeutic approaches - Potential clinical applications of cell based therapies for bone repair - Data reported in clinical studies • Selected paediatric bone disorders and cellular therapies - Inborn errors of bone metabolism and cellular therapy - Degenerative bone disorders in childhood • Ethical aspects of EU clinical trials - Ethics related to information and consent - Approval of the studies - Ethics related to privacy/data protection - Ethics related to the risk-benefit assessment - Ethics related to protection of the health of persons involved in clinical trials - Ethics related to transparency regarding research results • Future directions and remarks Regenerative medicine seeks to repair or replace damaged tissues or organs, with the goal to fully restore structure and function without the formation of scar tissue. Cell based therapies are promising new therapeutic approaches in regenerative medicine. By using mesenchymal stem cells, good results have been reported for bone engineering in a number of clinical studies, most of them investigator initiated trials with limited scope with respect to controls and outcome. With the implementation of a new regulatory framework for advanced therapeutic medicinal products, the stage is set to improve both the characterization of the cells and combination products, and pave the way for improved controlled and well-designed clinical trials. The incorporation of more personalized medicine approaches, including the use of biomarkers to identify the proper patients and the responders to treatment, will be contributing to progress in the field. Both translational and clinical research will move the boundaries in the field of regenerative medicine, and a coordinated effort will provide the clinical breakthroughs, particularly in the many applications of bone engineering.

Original languageEnglish
Pages (from-to)1266-1286
Number of pages21
JournalJournal of Cellular and Molecular Medicine
Volume15
Issue number6
DOIs
Publication statusPublished - Jun 2011

Fingerprint

Traumatology
Bone Regeneration
Cell- and Tissue-Based Therapy
Orthopedics
Stem Cells
Bone and Bones
Regenerative Medicine
Clinical Ethics
Ethics
Clinical Trials
Tissue Engineering
Mesenchymal Stromal Cells
Therapeutics
Computer Security
Inborn Errors Metabolism
Precision Medicine
Translational Medical Research
Clinical Studies
Privacy
Biocompatible Materials

Keywords

  • Bone regeneration
  • Clinical studies
  • Ethics
  • Regenerative medicine
  • Stem cell therapy

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Medicine

Cite this

Bone regeneration : Stem cell therapies and clinical studies in orthopaedics and traumatology. / Gómez-Barrena, Enrique; Rosset, Philippe; Müller, Ingo; Giordano, Rosaria; Bunu, Carmen; Layrolle, Pierre; Konttinen, Yrjö T.; Luyten, Frank P.

In: Journal of Cellular and Molecular Medicine, Vol. 15, No. 6, 06.2011, p. 1266-1286.

Research output: Contribution to journalArticle

Gómez-Barrena, E, Rosset, P, Müller, I, Giordano, R, Bunu, C, Layrolle, P, Konttinen, YT & Luyten, FP 2011, 'Bone regeneration: Stem cell therapies and clinical studies in orthopaedics and traumatology', Journal of Cellular and Molecular Medicine, vol. 15, no. 6, pp. 1266-1286. https://doi.org/10.1111/j.1582-4934.2011.01265.x
Gómez-Barrena, Enrique ; Rosset, Philippe ; Müller, Ingo ; Giordano, Rosaria ; Bunu, Carmen ; Layrolle, Pierre ; Konttinen, Yrjö T. ; Luyten, Frank P. / Bone regeneration : Stem cell therapies and clinical studies in orthopaedics and traumatology. In: Journal of Cellular and Molecular Medicine. 2011 ; Vol. 15, No. 6. pp. 1266-1286.
@article{4e52456fdfb444dc824cf2d0a33c24f6,
title = "Bone regeneration: Stem cell therapies and clinical studies in orthopaedics and traumatology",
abstract = "• Introduction • Characterization of cells for bone regeneration in human beings • State of the art in bone tissue engineering - Biomaterials for scaffolding mesenchymal stem cells - Future trends in bone tissue engineering • Clinical targets for cell therapy in orthopaedics - Current clinical problems and therapeutic approaches - Potential clinical applications of cell based therapies for bone repair - Data reported in clinical studies • Selected paediatric bone disorders and cellular therapies - Inborn errors of bone metabolism and cellular therapy - Degenerative bone disorders in childhood • Ethical aspects of EU clinical trials - Ethics related to information and consent - Approval of the studies - Ethics related to privacy/data protection - Ethics related to the risk-benefit assessment - Ethics related to protection of the health of persons involved in clinical trials - Ethics related to transparency regarding research results • Future directions and remarks Regenerative medicine seeks to repair or replace damaged tissues or organs, with the goal to fully restore structure and function without the formation of scar tissue. Cell based therapies are promising new therapeutic approaches in regenerative medicine. By using mesenchymal stem cells, good results have been reported for bone engineering in a number of clinical studies, most of them investigator initiated trials with limited scope with respect to controls and outcome. With the implementation of a new regulatory framework for advanced therapeutic medicinal products, the stage is set to improve both the characterization of the cells and combination products, and pave the way for improved controlled and well-designed clinical trials. The incorporation of more personalized medicine approaches, including the use of biomarkers to identify the proper patients and the responders to treatment, will be contributing to progress in the field. Both translational and clinical research will move the boundaries in the field of regenerative medicine, and a coordinated effort will provide the clinical breakthroughs, particularly in the many applications of bone engineering.",
keywords = "Bone regeneration, Clinical studies, Ethics, Regenerative medicine, Stem cell therapy",
author = "Enrique G{\'o}mez-Barrena and Philippe Rosset and Ingo M{\"u}ller and Rosaria Giordano and Carmen Bunu and Pierre Layrolle and Konttinen, {Yrj{\"o} T.} and Luyten, {Frank P.}",
year = "2011",
month = "6",
doi = "10.1111/j.1582-4934.2011.01265.x",
language = "English",
volume = "15",
pages = "1266--1286",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Bone regeneration

T2 - Stem cell therapies and clinical studies in orthopaedics and traumatology

AU - Gómez-Barrena, Enrique

AU - Rosset, Philippe

AU - Müller, Ingo

AU - Giordano, Rosaria

AU - Bunu, Carmen

AU - Layrolle, Pierre

AU - Konttinen, Yrjö T.

AU - Luyten, Frank P.

PY - 2011/6

Y1 - 2011/6

N2 - • Introduction • Characterization of cells for bone regeneration in human beings • State of the art in bone tissue engineering - Biomaterials for scaffolding mesenchymal stem cells - Future trends in bone tissue engineering • Clinical targets for cell therapy in orthopaedics - Current clinical problems and therapeutic approaches - Potential clinical applications of cell based therapies for bone repair - Data reported in clinical studies • Selected paediatric bone disorders and cellular therapies - Inborn errors of bone metabolism and cellular therapy - Degenerative bone disorders in childhood • Ethical aspects of EU clinical trials - Ethics related to information and consent - Approval of the studies - Ethics related to privacy/data protection - Ethics related to the risk-benefit assessment - Ethics related to protection of the health of persons involved in clinical trials - Ethics related to transparency regarding research results • Future directions and remarks Regenerative medicine seeks to repair or replace damaged tissues or organs, with the goal to fully restore structure and function without the formation of scar tissue. Cell based therapies are promising new therapeutic approaches in regenerative medicine. By using mesenchymal stem cells, good results have been reported for bone engineering in a number of clinical studies, most of them investigator initiated trials with limited scope with respect to controls and outcome. With the implementation of a new regulatory framework for advanced therapeutic medicinal products, the stage is set to improve both the characterization of the cells and combination products, and pave the way for improved controlled and well-designed clinical trials. The incorporation of more personalized medicine approaches, including the use of biomarkers to identify the proper patients and the responders to treatment, will be contributing to progress in the field. Both translational and clinical research will move the boundaries in the field of regenerative medicine, and a coordinated effort will provide the clinical breakthroughs, particularly in the many applications of bone engineering.

AB - • Introduction • Characterization of cells for bone regeneration in human beings • State of the art in bone tissue engineering - Biomaterials for scaffolding mesenchymal stem cells - Future trends in bone tissue engineering • Clinical targets for cell therapy in orthopaedics - Current clinical problems and therapeutic approaches - Potential clinical applications of cell based therapies for bone repair - Data reported in clinical studies • Selected paediatric bone disorders and cellular therapies - Inborn errors of bone metabolism and cellular therapy - Degenerative bone disorders in childhood • Ethical aspects of EU clinical trials - Ethics related to information and consent - Approval of the studies - Ethics related to privacy/data protection - Ethics related to the risk-benefit assessment - Ethics related to protection of the health of persons involved in clinical trials - Ethics related to transparency regarding research results • Future directions and remarks Regenerative medicine seeks to repair or replace damaged tissues or organs, with the goal to fully restore structure and function without the formation of scar tissue. Cell based therapies are promising new therapeutic approaches in regenerative medicine. By using mesenchymal stem cells, good results have been reported for bone engineering in a number of clinical studies, most of them investigator initiated trials with limited scope with respect to controls and outcome. With the implementation of a new regulatory framework for advanced therapeutic medicinal products, the stage is set to improve both the characterization of the cells and combination products, and pave the way for improved controlled and well-designed clinical trials. The incorporation of more personalized medicine approaches, including the use of biomarkers to identify the proper patients and the responders to treatment, will be contributing to progress in the field. Both translational and clinical research will move the boundaries in the field of regenerative medicine, and a coordinated effort will provide the clinical breakthroughs, particularly in the many applications of bone engineering.

KW - Bone regeneration

KW - Clinical studies

KW - Ethics

KW - Regenerative medicine

KW - Stem cell therapy

UR - http://www.scopus.com/inward/record.url?scp=79957650575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957650575&partnerID=8YFLogxK

U2 - 10.1111/j.1582-4934.2011.01265.x

DO - 10.1111/j.1582-4934.2011.01265.x

M3 - Article

VL - 15

SP - 1266

EP - 1286

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

IS - 6

ER -